EORTC presentations at ENCR Scientific Meeting in Baveno, Italy Oct 5-7 2016
5 Oct 2016
EORTC is conducting epidemiological outcome research, in partnership with population-based cancer registries in Europe, in part to evaluate real-world effectiveness of treatments tested in clinical research. As part of this, two studies will be presented as oral presentations at the European Network of Cancer Registries Scientific Meeting on October 7 under the theme ‘Cancer Registries and Clinical Data’.
The first study “Survival differences in Hodgkin lymphoma patients treated inside and outside clinical trials” will link data from six EORTC lymphoma trials and the Netherlands Cancer Registry (IKNL) to evaluate trial participation rate.
The same data is further linked with the Netherlands Patients Reported Outcome Cancer Registry (PROFILES) in the context of the second study: “Quality of life according to trial participation among Hodgkin lymphoma survivors.” Both studies are conducted in partnership with IKNL.
Related News
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
